These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 9241623)
1. Effects of simvastatin and enalapril on serum lipoprotein concentrations and left ventricular mass in patients on dialysis. The Perfect Study Collaborative Group. Robson R; Collins J; Johnson R; Kitching R; Searle M; Walker R; Douglas J; Leary J; Whalley G; Sharpe N; MacMahon S J Nephrol; 1997; 10(1):33-40. PubMed ID: 9241623 [TBL] [Abstract][Full Text] [Related]
2. Rationale and design features of a clinical trial examining the effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT). SCAT Investigators. Teo KK; Burton JR; Buller C; Plante S; Yokoyama S; Montague TJ Can J Cardiol; 1997 Jun; 13(6):591-9. PubMed ID: 9215232 [TBL] [Abstract][Full Text] [Related]
3. Effect of treatment with simvastatin on serum cholesteryl ester transfer in patients on dialysis. PERFECT Study Collaborative Group. Walker RJ; Sutherland WH; Walker HL; MacMahon S; Robson RA Nephrol Dial Transplant; 1997 Jan; 12(1):87-92. PubMed ID: 9027779 [TBL] [Abstract][Full Text] [Related]
4. Randomized placebo-controlled study of the effects of simvastatin on haemostatic variables, lipoproteins and free fatty acids. The Oxford Cholesterol Study Group. Mitropoulos KA; Armitage JM; Collins R; Meade TW; Reeves BE; Wallendszus KR; Wilson SS; Lawson A; Peto R Eur Heart J; 1997 Feb; 18(2):235-41. PubMed ID: 9043839 [TBL] [Abstract][Full Text] [Related]
5. ACE inhibitors captopril and enalapril induce regression of left ventricular hypertrophy in hypertensive patients with chronic renal failure. Dyadyk AI; Bagriy AE; Lebed IA; Yarovaya NF; Schukina EV; Taradin GG Nephrol Dial Transplant; 1997 May; 12(5):945-51. PubMed ID: 9175047 [TBL] [Abstract][Full Text] [Related]
6. Effect of simvastatin on qualitative and quantitative changes of lipoprotein metabolism in CAPD patients. Wanner C; Lubrich-Birkner I; Summ O; Wieland H; Schollmeyer P Nephron; 1992; 62(1):40-6. PubMed ID: 1436290 [TBL] [Abstract][Full Text] [Related]
7. Long-term effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: The Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT). Teo KK; Burton JR; Buller CE; Plante S; Catellier D; Tymchak W; Dzavik V; Taylor D; Yokoyama S; Montague TJ Circulation; 2000 Oct; 102(15):1748-54. PubMed ID: 11023927 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy. Suzuki H; Kanno Y; Kaneko K; Kaneko M; Kotaki S; Mimura T; Takane H Ther Apher Dial; 2004 Aug; 8(4):320-7. PubMed ID: 15274684 [TBL] [Abstract][Full Text] [Related]
9. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia. Saku K; Sasaki J; Arakawa K Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571 [TBL] [Abstract][Full Text] [Related]
10. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study. Luque Otero M; Martell Claros N; Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479 [TBL] [Abstract][Full Text] [Related]
11. Effects of HMG-CoA reductase inhibitors in hypercholesterolemic patients on hemodialysis. Wanner C; Hörl WH; Luley CH; Wieland H Kidney Int; 1991 Apr; 39(4):754-60. PubMed ID: 2051734 [TBL] [Abstract][Full Text] [Related]
12. The effects of simvastatin on serum lipoproteins in severe hypercholesterolaemia. Mol MJ; Stuyt PM; Demacker PN; Stalenhoef AF Neth J Med; 1990 Apr; 36(3-4):182-90. PubMed ID: 2355995 [TBL] [Abstract][Full Text] [Related]
13. Comparative effects of simvastatin and lovastatin in patients with hypercholesterolemia. The Simvastatin and Lovastatin Multicenter Study Participants. Farmer JA; Washington LC; Jones PH; Shapiro DR; Gotto AM; Mantell G Clin Ther; 1992; 14(5):708-17. PubMed ID: 1468089 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic effects of simvastatin on hyperlipidemia in CAPD patients. Di Paolo B; Del Rosso G; Catucci G; Vocino V; Terenzio MG; Bonomini M; Suriani K; Albertazzi A ASAIO Trans; 1990; 36(3):M578-80. PubMed ID: 2252755 [TBL] [Abstract][Full Text] [Related]
16. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study. Akçiçek F; Ok E; Duman S; Kürsad S; Unsal A; Alev M; Atabay G; Basçi A Adv Perit Dial; 1996; 12():261-5. PubMed ID: 8865916 [TBL] [Abstract][Full Text] [Related]
17. Effect of simvastatin given alone and in combination with valsartan or enalapril on blood pressure and the structure of mesenteric resistance arteries and the basilar artery in the genetically hypertensive rat model. Ledingham JM; Laverty R Clin Exp Pharmacol Physiol; 2005; 32(1-2):76-85. PubMed ID: 15730439 [TBL] [Abstract][Full Text] [Related]
18. Effect of simvastatin on plasma lipid and lipoprotein concentrations and low-density lipoprotein metabolism in the nephrotic syndrome. Warwick GL; Packard CJ; Murray L; Grierson D; Stewart JP; Shepherd J; Boulton-Jones JM Clin Sci (Lond); 1992 Jun; 82(6):701-8. PubMed ID: 1320552 [TBL] [Abstract][Full Text] [Related]
19. Beta-blockers vs. angiotensin-converting enzyme inhibitors in hypertension: effects on left ventricular hypertrophy. Gosse P; Roudaut R; Herrero G; Dallocchio M J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S145-50. PubMed ID: 11527119 [TBL] [Abstract][Full Text] [Related]
20. The effect of simvastatin on dyslipemia in continuous ambulatory peritoneal dialysis patients. Dimitriadis A; Antoniou S; Hatzisavvas N; Pastore F; Kaldi I; Stangou M Perit Dial Int; 1993; 13 Suppl 2():S434-6. PubMed ID: 8399633 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]